Jonathan McNeill - Jul 11, 2023 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Chief Business Officer
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Stock symbol
DYN
Transactions as of
Jul 11, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2024, 09:06 PM
Previous filing
Jun 14, 2023
Next filing
Sep 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock option (right to buy) Award $0 +35K $0.00 35K Jul 11, 2023 Common Stock 35K $11.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported late due to an inadvertent administrative error.
F2 This option award was granted on July 11, 2023 and vests over four years in equal monthly installments, with the first vesting occurring on August 1, 2023 and the remaining vesting occurring each month subsequent to the first vesting date, subject to continuous service.